Experts in many corners of Penn Medicine are at work combatting the deadly toll of the opioid epidemic, including the physicians and researchers of the Center for Health Incentives and Behavioral Economics (CHIBE) at the Perelman School of Medicine. As one of two Roybal Centers on Behavioral Economics and Health nationally funded by the National Institute of Aging of NIH, CHIBE combines psychology and economics with clinical expertise in an effort to understand why individuals make certain decisions that impact their health and how to leverage their findings to advance policy, improve health care delivery, and encourage healthy behaviors among patients and best practices among clinicians. All those elements combine in their efforts to curb prescription opioid misuse.
Latest CLIC Content
Latest News from Around the CTSA Program Consortium
CHIBE Combats the Opioid Crisis, One ‘Nudge’ at a Time
Penn Medicine CTSA
June 21, 2018
Pioneering new eczema treatments: Donald Leung, MD, pits good bacteria against bad in his research
Colorado Clinical and Translational Sciences Institute
The battle between good and evil is a theme usually reserved for blockbuster movies or literature. However, biomedical researcher Donald Leung, MD, is engaged in his own epic battle, pitting good bacteria against bad in order to treat atopic dermatitis or eczema—the world’s most common skin disease.
June 20, 2018
Hundreds of research Scholars across the U.S. benefit from CTSI-hosted Mock Study Sections
University of Minnesota's Clinical and Translational Science Institute (CTSI)
More than 300 pre- and post -doctoral students and junior faculty Scholars at the national Association for Clinical and Translational Science (ACTS) Conference have participated in a Mock Study Section hosted by the University of Minnesota CTSI’s Research Education, Training, and Career Development team since 2016. After three years of hosting the event, the University of Minnesota CTSI has passed the baton to the Indiana Clinical and Translational Science Institute (CTSI), who will host the ACTS Conference Mock Study Section in 2019.
June 20, 2018
New Study Shows Medication-Based Treatment After Opioid Overdose Can Save Lives
Boston University CTSI
Survivors of opioid overdose have a higher risk of death than individuals who have not experienced an overdose. Effective strategies to lower that risk are critically important to combatting the opioid epidemic in the United States.
Medications to treat opioid use disorder (OUD) are one potential strategy, but research about the effect of medication use on survival after an overdose is limited. To address that gap, a team led by researchers from the Boston University CTSI reviewed medical records for more than 17,500 adults who had survived an opioid overdose.
June 19, 2018